[18F]FES PET

You have access
Intrapatient 16α-[¹⁸F]Fluoro-17β-Estradiol PET Heterogeneity as a Prognostic Factor for Endocrine Therapy Response and Survival in Patients with Estrogen Receptor–Positive Metastatic Breast Cancer
Jasper J.L. van Geel, Jasmine Moustaquim, Jorianne Boers, Sjoerd G. Elias, Esther M.M. Smeets, Jelijn J. Knip, Andor W.J.M. Glaudemans, Erik F.J. de Vries, Geke A.P. Hospers, Michel van Kruchten, Marcel Stokkel, Daniela E. Oprea-Lager, Willemien C. Menke-van der Houven van Oordt, Elisabeth G.E. de Vries and Carolina P. Schröder; on behalf of the IMPACT-Metastatic Breast Consortium

Journal of Nuclear Medicine February 1, 2025, 66 (2) 194-200; DOI: https://doi.org/10.2967/jnumed.124.268984
You have access
Summary: SNMMI Procedure Standard/EANM Practice Guideline for Estrogen Receptor Imaging of Patients with Breast Cancer Using 16α-[¹⁸F]Fluoro-17β-Estradiol PET
David Mankoff, Soňa Balogová, Lisa Dunnwald, Farrokh Dehdashti, Erik DeVries, Laura Evangelista, Michel Van Kruchten, Sofia Carrilho Vaz, Amy Fowler, Hannah Linden and Gary A. Ulaner

Journal of Nuclear Medicine February 1, 2024, 65 (2) 221-223; DOI: https://doi.org/10.2967/jnumed.123.266938

Main menu